11-68446521-C-T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2

The NM_002335.4(LRP5):​c.4574C>T​(p.Ala1525Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0106 in 1,613,754 control chromosomes in the GnomAD database, including 121 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A1525A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0096 ( 11 hom., cov: 32)
Exomes 𝑓: 0.011 ( 110 hom. )

Consequence

LRP5
NM_002335.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 0.511

Publications

20 publications found
Variant links:
Genes affected
LRP5 (HGNC:6697): (LDL receptor related protein 5) This gene encodes a transmembrane low-density lipoprotein receptor that binds and internalizes ligands in the process of receptor-mediated endocytosis. This protein also acts as a co-receptor with Frizzled protein family members for transducing signals by Wnt proteins and was originally cloned on the basis of its association with type 1 diabetes mellitus in humans. This protein plays a key role in skeletal homeostasis and many bone density related diseases are caused by mutations in this gene. Mutations in this gene also cause familial exudative vitreoretinopathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
LRP5 Gene-Disease associations (from GenCC):
  • bone mineral density quantitative trait locus 1
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • exudative vitreoretinopathy 4
    Inheritance: AD, SD, Unknown Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, Laboratory for Molecular Medicine
  • inherited retinal dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • osteoporosis-pseudoglioma syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • autosomal dominant osteosclerosis, Worth type
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • polycystic liver disease 4 with or without kidney cysts
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • autosomal dominant osteopetrosis 1
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
  • exudative vitreoretinopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hyperostosis corticalis generalisata
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • osteosclerosis-developmental delay-craniosynostosis syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • polycystic liver disease 1
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

PP2
Missense variant in the LRP5 gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 71 curated pathogenic missense variants (we use a threshold of 10). The gene has 23 curated benign missense variants. Gene score misZ: 1.6684 (below the threshold of 3.09). Trascript score misZ: 3.6986 (above the threshold of 3.09). GenCC associations: The gene is linked to exudative vitreoretinopathy 4, autosomal dominant osteopetrosis 1, osteoporosis-pseudoglioma syndrome, autosomal dominant osteosclerosis, Worth type, polycystic liver disease 4 with or without kidney cysts, bone mineral density quantitative trait locus 1, osteosclerosis-developmental delay-craniosynostosis syndrome, hyperostosis corticalis generalisata, exudative vitreoretinopathy, polycystic liver disease 1, inherited retinal dystrophy.
BP4
Computational evidence support a benign effect (MetaRNN=0.0074311197).
BP6
Variant 11-68446521-C-T is Benign according to our data. Variant chr11-68446521-C-T is described in ClinVar as Benign. ClinVar VariationId is 195672.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00958 (1460/152332) while in subpopulation NFE AF = 0.0112 (764/68020). AF 95% confidence interval is 0.0106. There are 11 homozygotes in GnomAd4. There are 656 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 11 AD,AR,SD,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRP5NM_002335.4 linkc.4574C>T p.Ala1525Val missense_variant Exon 22 of 23 ENST00000294304.12 NP_002326.2 O75197

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRP5ENST00000294304.12 linkc.4574C>T p.Ala1525Val missense_variant Exon 22 of 23 1 NM_002335.4 ENSP00000294304.6 O75197
LRP5ENST00000529993.5 linkn.*3180C>T non_coding_transcript_exon_variant Exon 22 of 23 1 ENSP00000436652.1 E9PHY1
LRP5ENST00000529993.5 linkn.*3180C>T 3_prime_UTR_variant Exon 22 of 23 1 ENSP00000436652.1 E9PHY1
LRP5ENST00000529702.1 linkc.242C>T p.Ala81Val missense_variant Exon 3 of 4 3 ENSP00000435315.1 H0YE98

Frequencies

GnomAD3 genomes
AF:
0.00959
AC:
1460
AN:
152214
Hom.:
11
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0105
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0100
Gnomad ASJ
AF:
0.0104
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00489
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0112
Gnomad OTH
AF:
0.00911
GnomAD2 exomes
AF:
0.00770
AC:
1934
AN:
251260
AF XY:
0.00746
show subpopulations
Gnomad AFR exome
AF:
0.0106
Gnomad AMR exome
AF:
0.00506
Gnomad ASJ exome
AF:
0.00794
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00533
Gnomad NFE exome
AF:
0.0118
Gnomad OTH exome
AF:
0.00847
GnomAD4 exome
AF:
0.0107
AC:
15642
AN:
1461422
Hom.:
110
Cov.:
31
AF XY:
0.0103
AC XY:
7482
AN XY:
727050
show subpopulations
African (AFR)
AF:
0.00959
AC:
321
AN:
33478
American (AMR)
AF:
0.00537
AC:
240
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00765
AC:
200
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.000220
AC:
19
AN:
86252
European-Finnish (FIN)
AF:
0.00613
AC:
327
AN:
53334
Middle Eastern (MID)
AF:
0.00416
AC:
24
AN:
5768
European-Non Finnish (NFE)
AF:
0.0125
AC:
13939
AN:
1111656
Other (OTH)
AF:
0.00947
AC:
572
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
741
1482
2223
2964
3705
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
524
1048
1572
2096
2620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00958
AC:
1460
AN:
152332
Hom.:
11
Cov.:
32
AF XY:
0.00881
AC XY:
656
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.0105
AC:
435
AN:
41588
American (AMR)
AF:
0.0100
AC:
153
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0104
AC:
36
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00489
AC:
52
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0112
AC:
764
AN:
68020
Other (OTH)
AF:
0.00901
AC:
19
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
77
154
232
309
386
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0105
Hom.:
31
Bravo
AF:
0.00986
TwinsUK
AF:
0.0165
AC:
61
ALSPAC
AF:
0.0132
AC:
51
ESP6500AA
AF:
0.00864
AC:
38
ESP6500EA
AF:
0.00978
AC:
84
ExAC
AF:
0.00787
AC:
956
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.0101
EpiControl
AF:
0.0114

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:8
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

LRP5: BP4, BS1, BS2 -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 16956801) -

Sep 18, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Jul 17, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Osteogenesis imperfecta Benign:1
Jul 18, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Osteoporosis with pseudoglioma;C0432273:Worth disease;C1843330:Autosomal dominant osteopetrosis 1;C1851402:Exudative vitreoretinopathy 1;C1866176:Exudative vitreoretinopathy 4;C4693479:Polycystic liver disease 4 with or without kidney cysts Benign:1
Jun 15, 2023
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.079
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.19
CADD
Benign
17
DANN
Benign
0.81
DEOGEN2
Benign
0.32
T
Eigen
Benign
-0.56
Eigen_PC
Benign
-0.62
FATHMM_MKL
Benign
0.21
N
LIST_S2
Benign
0.83
T
MetaRNN
Benign
0.0074
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.90
L
PhyloP100
0.51
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-0.58
N
REVEL
Benign
0.16
Sift
Benign
0.43
T
Sift4G
Benign
0.50
T
Polyphen
0.0060
B
Vest4
0.12
MVP
0.53
MPC
0.41
ClinPred
0.013
T
GERP RS
3.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.045
gMVP
0.22
Mutation Taster
=98/2
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1127291; hg19: chr11-68213989; COSMIC: COSV99037169; COSMIC: COSV99037169; API